Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patientsGudrun David Sigmo, Solveig Hauge, Karl Ove Hufthammer, Marianne Wallenius, Kjell Åsmund Salvesen, Anne Kjersti Nesje Daltveit, Gunnstein Bakland, Bjorg-Tilde Svanes Fevang
23 January 2024
Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trialMax M H Teuwen, Salima F E van Weely, Thea P M Vliet Vlieland, Maria A T van Wissen, Wilfred F Peter, Alfons A den Broeder, Dirkjan van Schaardenburg, Wilbert B van den Hout, Cornelia H M Van den Ende, Maaike G J Gademan
3 January 2024
Correction: Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL SurveillanceBMJ Publishing Group Ltd and European League Against Rheumatism
15 February 2024
Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumaticaEugenio De Miguel, Rositsa Karalilova, Pierluigi Macchioni, Cristina Ponte, Edoardo Conticini, Sharon Cowley, Alessandro Tomelleri, Sara Monti, Irene Monjo, Zguro Batalov, Giulia Klinowski, Paolo Falsetti, David J Kane, Corrado Campochiaro, Alojzija Hočevar
6 November 2023
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trialReza Zonozi, Frank B Cortazar, Anushya Jeyabalan, Gabriel Sauvage, Pravarut Nithagon, Noah R Huizenga, Jillian M Rosenthal, Alexander Sipilief, Katherine Cosgrove, Karen A Laliberte, Eugene P Rhee, William F Pendergraft, III, John L Niles
11 December 2023
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trialsFlorence Delestre, Pierre Charles, Alexandre Karras, Christian Pagnoux, Antoine Néel, Pascal Cohen, Olivier Aumaître, Stanislas Faguer, Pierre Gobert, François Maurier, Maxime Samson, Pascal Godmer, Bernard Bonnotte, Vincent Cottin, Catherine Hanrotel-SaliouSee the full list of authors
2 November 2023
Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centresMatthias Dreher, Torsten Witte, Kirsten Hoeper, Gunter Assmann, Fabian Proft, Denis Poddubnyy, Niels Murawski, Konstantinos Triantafyllias, Marlon Grodd, Erika Graf, Urs A Fichtner, Harald Binder, Jan Zeidler, Juliana Rachel Hoeper, Johanna CallhoffSee the full list of authors
27 October 2023
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up studyShunsuke Furuta, Daiki Nakagomi, Yoshihisa Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin-ichiro KagamiSee the full list of authors
21 September 2023
Global, regional and national temporal trends in prevalence for musculoskeletal disorders in women of childbearing age, 1990–2019: an age-period-cohort analysis based on the Global Burden of Disease Study 2019Fan Cao, Da-Peng Li, Guo-Cui Wu, Yi-Sheng He, Yu-Chen Liu, Jing-Jing Hou, Qin-Yu Ni, Li-Ming Tao, Zheng-Xuan Jiang, Hai-Feng Pan
4 September 2023
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trialLisa Stamp, Anne Horne, Borislav Mihov, Jill Drake, Janine Haslett, Peter T Chapman, Christopher Frampton, Nicola Dalbeth
31 August 2023